709 related articles for article (PubMed ID: 27873247)
1. Computer-Aided Drug Design Methods.
Yu W; MacKerell AD
Methods Mol Biol; 2017; 1520():85-106. PubMed ID: 27873247
[TBL] [Abstract][Full Text] [Related]
2. Computer-Aided Drug Design: An Update.
Yu W; Weber DJ; MacKerell AD
Methods Mol Biol; 2023; 2601():123-152. PubMed ID: 36445582
[TBL] [Abstract][Full Text] [Related]
3. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
[TBL] [Abstract][Full Text] [Related]
4. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Abdolmaleki A; Ghasemi JB; Ghasemi F
Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
[TBL] [Abstract][Full Text] [Related]
5. Strategy of computer-aided drug design.
Veselovsky AV; Ivanov AS
Curr Drug Targets Infect Disord; 2003 Mar; 3(1):33-40. PubMed ID: 12570731
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules.
Yu W; Lakkaraju SK; Raman EP; Fang L; MacKerell AD
J Chem Inf Model; 2015 Feb; 55(2):407-20. PubMed ID: 25622696
[TBL] [Abstract][Full Text] [Related]
7. Application of Virtual Screening Approaches for the Identification of Small Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.
Luise C; Robaa D
Methods Mol Biol; 2018; 1824():347-370. PubMed ID: 30039418
[TBL] [Abstract][Full Text] [Related]
8. Computer-Aided Drug Design: An Overview.
Talevi A
Methods Mol Biol; 2018; 1762():1-19. PubMed ID: 29594764
[TBL] [Abstract][Full Text] [Related]
9. Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
[TBL] [Abstract][Full Text] [Related]
10. Integrating structure-based and ligand-based approaches for computational drug design.
Wilson GL; Lill MA
Future Med Chem; 2011 Apr; 3(6):735-50. PubMed ID: 21554079
[TBL] [Abstract][Full Text] [Related]
11. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
[TBL] [Abstract][Full Text] [Related]
12. Protein structure-based drug design: from docking to molecular dynamics.
Śledź P; Caflisch A
Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
[TBL] [Abstract][Full Text] [Related]
14. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
15. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
Vucicevic J; Nikolic K; Mitchell JBO
Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
[TBL] [Abstract][Full Text] [Related]
16. A review of protein-small molecule docking methods.
Taylor RD; Jewsbury PJ; Essex JW
J Comput Aided Mol Des; 2002 Mar; 16(3):151-66. PubMed ID: 12363215
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided design of GPCR ligands.
Gutiérrez-de-Terán H; Keränen H; Azuaje J; Rodríguez D; Åqvist J; Sotelo E
Methods Mol Biol; 2015; 1272():271-91. PubMed ID: 25563191
[TBL] [Abstract][Full Text] [Related]
18. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
19. Use of machine learning approaches for novel drug discovery.
Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
[TBL] [Abstract][Full Text] [Related]
20. Receptor-based virtual screening protocol for drug discovery.
Cerqueira NM; Gesto D; Oliveira EF; Santos-Martins D; Brás NF; Sousa SF; Fernandes PA; Ramos MJ
Arch Biochem Biophys; 2015 Sep; 582():56-67. PubMed ID: 26045247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
